Gardasil 9

国: ノルウェー

言語: ノルウェー語

ソース: Statens legemiddelverk

有効成分:

Humant papillomavirus, type 6 L1 protein, rekombinant / Humant papillomavirus, type 11 L1 protein, rekombinant / Humant papillomavirus, type 16 L1 protein, rekombinant / Humant papillomavirus, type 18 L1 protein, rekombinant / Humant papillomavirus, type 31 L1 protein, rekombinant / Humant papillomavirus, type 33 L1 protein, rekombinant / Humant papillomavirus, type 45 L1 protein, rekombinant / Humant papillomavirus, type 52 L1 protein, rekombinant / Humant papillomavirus, type 58 L1 protein, rekombinant

から入手可能:

Orifarm AS

ATCコード:

J07BM03

INN（国際名）:

Humant papillomavirus, type 6 L1 protein, rekombinant / Humant papillomavirus, type 11 L1 protein, rekombinant / Humant papillomavirus, type 16 L1 protein, rekombinant / Humant papillomavirus, type 18 L1 protein, rekombinant / Humant papillomavirus, type 31 L1 protein, rekombinant / Humant papillomavirus, type 33 L1 protein, rekombinant / Humant papillomavirus, type 45 L1 protein, rekombinant / Humant papillomavirus, type 52 L1 protein, rekombinant / Humant papillomavirus, type 58 L1 protein, rekombinant

医薬品形態:

Injeksjonsvæske, suspensjon

パッケージ内のユニット:

Ferdigfylt sprøyte 1x0.5 ml

処方タイプ:

C

認証ステータス:

Markedsført

承認日:

2022-04-01